Sign in

CIK 0001875091 · Non-accelerated filer<br>Emerging growth company

NeuroSense Therapeutics Ltd.

Sign in to watch
Ticker
NRSN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
other
Phone
972-9-9531142
Business address
11 HAMENOFIM ST., BUILDING B, HERZLIYA, Israel, 4672562

Securities

  • NRSN Ordinary Shares Nasdaq
  • NRSNW Warrant Nasdaq
  1. 4 Open-market buy Chief Executive Officer bought 250,000 shares at $0.80 ($200,000)
  2. 4 Open-market buy Chief Financial Officer bought 250,000 shares at $0.80 ($200,000)
  3. 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Chief Technology Officer acquired 200,000 shares (grant or award)
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award General Manager acquired 200,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership

Page 1 of 1 · 15 filings